EUVIMEDEUVIMED entdecken
Validierungsstudie

Development and validation of a flow cytometry-based ISG15 induction assay to monitor the type I interferon response

Birthe Michiels, Rudi Beyaert, Jens Staal, Doreen Dillaerts, Maaike Cockx, Glynis Frans, Birgit Timmermans, Natalie Lorent, Isabelle Meyts, Xavier Bossuyt

Clinical Immunology · 2026-02 · 283 · 110654

DOI: 10.1016/j.clim.2025.110654 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Clinical Immunology, 2026-02. Verfasst von Birthe Michiels und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium; Department of Microbiology, Immunology and Transplantation, Clinical…. Hauptthemen laut MEDLINE: Flow Cytometry, Cytokines, Ubiquitins, Interferon Type I. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Vlaams Instituut voor Biotechnologie, Jeffrey Modell Foundation, Fonds Wetenschappelijk Onderzoek.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The type I IFN response plays an important role in the immune defence against invading pathogens and in certain autoinflammatory diseases. In this study, a flow cytometry-based assay to measure ISG15 production in response to stimulation with various TLR ligands and IFNα was developed. PBMCs of healthy controls or patients were stimulated with TLR7/8, TLR3 and TLR9 ligands and IFNα2 whereafter ISG15 expression was measured. The ability of the assay to analyse TLR-dependent type I IFN induction and type I IFN-dependent JAK/STAT activation was verified by inhibition of ISG15 induction by a TBK1/IKKε inhibitor and a JAK1 inhibitor, respectively. TLR7/8 ligand- and TLR9 ligand-induced ISG15 production but not IFNα2-induced ISG15 production was abolished in a patient with AR IRF7 deficiency. IFNα2-induced ISG15 expression was abolished by serum containing neutralizing anti-IFNα2 autoantibodies. The flow cytometry-based ISG15 induction assay can be applied to screen for defects in the type I IFN response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Flow CytometryCytokinesUbiquitinsInterferon Type IHumansInterferon-alphaLeukocytes, MononuclearMaleFemaleToll-Like ReceptorsInterferon Regulatory Factor-7AdultAutoantibodies

Stichwörter der Autor:innen

Anti-IFNα2 autoantibodiesFlow cytometryIRF7ISG15TLRType I IFN response

Substanzen

CytokinesUbiquitinsISG15 protein, humanInterferon Type IInterferon-alphaToll-Like ReceptorsInterferon Regulatory Factor-7Autoantibodies

Autor:innen und Institutionen

  • Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium; Department of Microbiology, Immunology and Transplantation, Clinical and Diagnostic Immunology, KU Leuven, Leuven, Belgium. Electronic add…
  • Unit of Molecular Signal Transduction in Inflammation, VIB-UGent Center for Inflammation Research, Belgium; Department of Biomedical Molecular Biology, Ghent University, Belgium. Electronic address: rudi.beyaert@irc.vib…
  • Unit of Molecular Signal Transduction in Inflammation, VIB-UGent Center for Inflammation Research, Belgium; Department of Biomedical Molecular Biology, Ghent University, Belgium; Department of Biochemistry and Microbiol…
  • Department of Microbiology, Immunology and Transplantation, Clinical and Diagnostic Immunology, KU Leuven, Leuven, Belgium. Electronic address: doreen.dillaerts@uzleuven.be.
  • Department of Microbiology, Immunology and Transplantation, Clinical and Diagnostic Immunology, KU Leuven, Leuven, Belgium; PharmAbs, The KU Leuven Antibody Center, University of Leuven, Leuven, Belgium. Electronic addr…
  • Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium. Electronic address: birgit.timmermans@uzleuven.be.

Förderung

  • Vlaams Instituut voor Biotechnologie
  • Jeffrey Modell Foundation
  • Fonds Wetenschappelijk Onderzoek
  • KU Leuven
  • KU Leuven Research Council

Zitieren

APA

Michiels, B., Beyaert, R., Staal, J., Dillaerts, D., Cockx, M., Frans, G., Timmermans, B., Lorent, N., Meyts, I., & Bossuyt, X. (2026). Development and validation of a flow cytometry-based ISG15 induction assay to monitor the type I interferon response. Clinical Immunology, 283, 110654. https://doi.org/10.1016/j.clim.2025.110654

Vancouver

Michiels B, Beyaert R, Staal J, Dillaerts D, Cockx M, Frans G, et al. Development and validation of a flow cytometry-based ISG15 induction assay to monitor the type I interferon response. Clinical Immunology. 2026;283:110654. doi:10.1016/j.clim.2025.110654

BibTeX
@article{Michiels2026,
  author = {Michiels, Birthe and Beyaert, Rudi and Staal, Jens and Dillaerts, Doreen and Cockx, Maaike and Frans, Glynis and Timmermans, Birgit and Lorent, Natalie and Meyts, Isabelle and Bossuyt, Xavier},
  title = {Development and validation of a flow cytometry-based ISG15 induction assay to monitor the type I interferon response},
  journal = {Clinical Immunology},
  year = {2026},
  volume = {283},
  pages = {110654},
  doi = {10.1016/j.clim.2025.110654}
}
Kostenlos starten →